Abaco3 SpA has acquired Exprivia SpA
Abaco3 SpA has acquired 43.5% of Exprivia SpA through a voluntary public tender offer.
Abaco3 SpA is a vehicle created for the purpose of tendering Exprivia SpA.
Exprivia SpA is a listed Italian company than provides consultancy, technology services and information technology solutions.
Oaklins Italy’s parent company Banca Akros acted as the appointed broker in the collection of shares in the total voluntary public tender offer of 43.5% of Exprivia SpA by Abaco3 SpA.
Talk to the deal team
Related deals
Tekova Oyj has completed a technical listing on the Nasdaq First North Growth Market Finland
Tekova Oyj has successfully completed a technical listing (IPO) on the Nasdaq First North Growth Market Finland. This transaction marks a significant milestone in the company’s growth strategy, enhancing its visibility and access to capital markets.
Learn moreBayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
Learn moreGrupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
Learn more